Fumihiro Ishikawa Selected Research

benzohydrol (benzhydrol)

10/2020

Discovery of new benzhydrol biscarbonate esters as potent and selective apoptosis inducers of human melanomas bearing the activated ERK pathway: SAR studies on an ERK MAPK signaling modulator, ACA-28.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fumihiro Ishikawa Research Topics

Disease

8	Neoplasms (Cancer) 08/2021 - 10/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2012 - 07/2009
2	Breast Neoplasms (Breast Cancer) 08/2021 - 07/2016
2	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 12/2016 - 07/2014
1	COVID-19 12/2022
1	Hypoxia (Hypoxemia) 12/2022
1	Disease Progression 12/2022
1	Cross Infection (Nosocomial Infection) 12/2021
1	Melanoma (Melanoma, Malignant) 10/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Circulating Neoplastic Cells 12/2016
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Obesity 01/2014
1	Dehydration (Water Stress) 01/2014
1	Hyperglycemia 01/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013

Drug/Important Bio-Agent (IBA)

2	IntegrinsIBA 08/2021 - 10/2012
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 10/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2016 - 07/2014
2	Carrier Proteins (Binding Protein)IBA 01/2014 - 10/2012
1	C-Reactive ProteinIBA 12/2022
1	Cystatin CIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	NucleotidesIBA 12/2021
1	Actin-Related Protein 2IBA 08/2021
1	GTP Phosphohydrolases (GTPases)IBA 08/2021
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 08/2021
1	EstersIBA 10/2020
1	benzohydrol (benzhydrol)IBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Rabeprazole (Aciphex)FDA Link 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 07/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2014
1	CytokinesIBA 01/2014
1	PolyketidesIBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	1,5-anhydroglucitolIBA 01/2013
1	Sweetening Agents (Sweeteners)IBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	ChromatinIBA 10/2012
1	Histones (Histone)IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	ElementsIBA 10/2012
1	EnzymesIBA 06/2011
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 06/2011
1	XenobioticsIBA 07/2009

Therapy/Procedure

1	Therapeutics 10/2020
1	Precision Medicine 01/2020